Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet. Haematology 2021-06, Vol.8 (6), p.e389-e392
Hauptverfasser:	Bird, Sarah, Panopoulou, Aikaterini, Shea, Robyn L, Tsui, Micky, Saso, Radovan, Sud, Amit, West, Sharon, Smith, Katy, Barwood, John, Kaczmarek, Ewa, Panlaqui, Carmela, Kaiser, Martin, Stern, Simon, Pawlyn, Charlotte, Boyd, Kevin
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antibodies, Viral - blood Comment COVID-19 - blood COVID-19 - etiology COVID-19 - prevention & control COVID-19 Vaccines - adverse effects COVID-19 Vaccines - therapeutic use Humans Immunoglobulin G - blood Male Middle Aged Multiple Myeloma - blood Multiple Myeloma - complications Retrospective Studies Risk Factors SARS-CoV-2 - isolation & purification Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!